Ferguson PLC Results for the 3 months ended 30 April 2019

Ferguson PLC

CONTINUED GROWTH, RE-AFFIRMING GUIDANCE, $500 MILLION SHARE BUY BACK

Ongoing businesses1US$ millionsQ3 2019Q3 2018 Change
Revenue5,2744,968+6.2%
Trading profit2359351+2.3%
Net debt to EBITDA 0.9x0.9x3

 

Third quarter highlights

−          Ongoing revenue growth of 6.2%, including 8.4% in the USA.

−          Solid gross margins, slightly ahead of last year.

−          Good cost control, underlying operating costs lower than in Q2.

−          Ongoing trading profit of $359 million was $8 million ahead of last year.

−          Strong operating cash generation of $632 million in the quarter with net debt to EBITDA of 0.9x.

−          Share buy back of $500 million announced today.

 

John Martin, Group Chief Executive, commented:

“The Group continued to grow in Q3 with revenue 6.2% ahead. We also continued to successfully grow our gross margins and have improved our underlying cost base over the last two quarters.

“We are confident that Ferguson will continue to make progress as we remain firmly focused on delivering superior customer service. We expect to generate ongoing Group trading profit in the year ended 31 July 2019 in line with current analysts’ consensus forecasts.4

“Cash generation continued to be excellent and our balance sheet remains strong. We will continue to invest organically in our businesses supplemented by bolt-on acquisitions in our core operations. Given our strong financial position, and in line with our capital allocation policy, we are initiating a $500 million share buy back programme which we expect to complete over the next 12 months.”

Share on:

Latest Company News

Meren Energy begins trading on OTCQX Market

Meren Energy Inc. has announced that its common shares are now trading on the OTCQX Best Market in the United States under the ticker symbol MRNFF.

HUTCHMED unveils next-generation ATTC Platform and key R&D advances

HUTCHMED (China) Limited has introduced its next-generation Antibody-Targeted Therapy Conjugate (ATTC) platform and shared major pipeline updates at its 2025 R&D event.

Cerillion to announce FY2025 results on 24 November

Cerillion plc will release its final results for the year ended 30 September 2025 on Monday, 24 November 2025.

Aptamer Group reports strong FY2025 growth and expands Optimer® portfolio

Aptamer Group delivered strong progress in FY2025, achieving a 40% revenue increase and expanding its portfolio of licensable Optimer® assets from four to eleven.

MHA reports 13% revenue growth and confirms full-year outlook

MHA has announced a strong first half for FY26, with revenue rising 13% to £121.3 million and performance in line with market expectations.

Thor Energy advances HY-Range hydrogen and helium exploration

Thor Energy has reported a strategically significant quarter ending September 2025, marked by major progress at its HY-Range hydrogen and helium project in South Australia. The company recorded hydrogen values

    Search

    Search